IPP Bureau
Lupin receives USFDA nod for Famotidine injection
By IPP Bureau - May 15, 2026
Famotidine Injection USP is a generic version of Pepcid injection to be manufactured at its Nagpur facility for the U.S. market
Indoco Remedies' Baddi plant gets EU GMP approval from Malta Medicines Authority
By IPP Bureau - May 15, 2026
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
Alembic Pharma receives USFDA tentative approval for Darolutamide tablets
By IPP Bureau - May 15, 2026
Darolutamide Tablets, 300 mg, had an estimated market size of US$ 3,155 million in the United States
Telangana life sciences ecosystem reaches $145 billion valuation
By IPP Bureau - May 15, 2026
The state has received Rs. 84,000 crore investments in the sector over two years, positioning Hyderabad among the world’s leading life sciences clusters
Senores Pharma reports 62% rise in FY26 total income to Rs. 664 crore
By IPP Bureau - May 15, 2026
The company reported a 108% rise in profit after tax, driven by strong growth in regulated markets, branded generics, and U.S. expansion initiatives
OneSource records Rs. 4,282 million revenue in Q4 FY26
By IPP Bureau - May 15, 2026
Backed by Semaglutide launches, the company reported 47% quarter-on-quarter revenue growth in Q4 FY26, with EBITDA expanding more than fivefold
Cipla achieves highest-ever annual revenue of Rs. 28,163 crore in FY26
By IPP Bureau - May 15, 2026
The company witnesses strong growth across its India, Africa, and emerging markets businesses, while securing regulatory approval for the first AB-rated gVentolin in the U.S. market
Lilly and UNICEF launch $50M push to reach 30 million children with life-saving health care
By IPP Bureau - May 15, 2026
The target reach is of more than 30 million young people and caregivers across 21 countries
Imfinzi-based regimens deliver major survival gains in muscle-invasive bladder cancer
By IPP Bureau - May 15, 2026
The study has shown that perioperative treatment with Imfinzi (durvalumab), alone or in combination with other immunotherapy agents
Akums posts strong FY26 performance as EBITDA surges 61.6% in Q4
By IPP Bureau - May 15, 2026
Senores Pharma doubles profit as sales surge 62%
By IPP Bureau - May 15, 2026
Global specialty pipeline accelerates growth
Merck to showcase 100+ oncology studies at 2026 ASCO meeting
By IPP Bureau - May 14, 2026
Highlighting KEYTRUDA & expanding cancer pipeline
Wegovy delivers consistent weight loss & heart benefits for women across menopause: Novo Nordisk study
By IPP Bureau - May 14, 2026
Nearly one in five women worldwide are now living with obesity
Bayer posts strong Q1 2026 results as Crop Science surge lifts earnings & outlook
By IPP Bureau - May 14, 2026
Net income more than doubled to 2.763 billion euros, while core earnings per share climbed 12.9 percent to 2.71 euros
Shilpa Medicare signs long-term CDMO pact with NXI Therapeutics to expand global biotech push
By IPP Bureau - May 14, 2026
Shilpa will deliver end-to-end services including CMC development, process scale-up, GMP clinical supply, and commercial manufacturing support
